Gavin Bennett
5PUBLICATIONS
34CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Mar 04, 2026
Unlocking the potential of EphA2 with precision-guided cancer therapy: bicycle drug conjugates.Gavin Bennett, Jitka Riedl, Gemma Mudd
|Sep 04, 2024
Results From First-in-Human Phase I Dose-Escalation Study of a Novel Bicycle Toxin Conjugate Targeting EphA2 (BT5528) in Patients With Advanced Solid Tumors.Babar Bashir, Judy S Wang, Gerald Falchook
|Dec 13, 2023
Bioanalysis of the Bicycle® toxin conjugate BT5528 and released monomethyl auristatin E via liquid chromatography-tandem mass spectrometry.Joseph A Tweed, Fern Adams-Dam, Jane Allanson
|Sep 16, 2022
BT8009; A Nectin-4 Targeting Bicycle Toxin Conjugate for Treatment of Solid Tumors.Michael Rigby, Gavin Bennett, Liuhong Chen
|May 14, 2020
MMAE Delivery Using the Bicycle Toxin Conjugate BT5528.Gavin Bennett, Amy Brown, Gemma Mudd
Pageof 1
Frequent Collaborators
2 joint publications
Amy N Brown
2 joint publications
Gemma Mudd
2 joint publications
Liuhong Chen
2 joint publications
Johanna Lahdenranta
2 joint publications
Hongmei Xu
2 joint publications
Phil Jeffrey
2 joint publications
Carly Campbell
1 joint publications
Michael Rigby
1 joint publications
Helen Harrison
1 joint publications
Katerine Van Rietschoten
